Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease

BACKGROUND: Bacterial infections are involved in more than a half of the exacerbations of chronic obstructive pulmonary disease (COPD). AIM: To evaluate the efficacy and safety of moxifloxacin in the outpatient treatment of moderate exacerbations of bacterial origin in the COPD patients. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Minov, Jordan, Stoleski, Sasho, Petrova, Tatjana, Vasilevska, Kristin, Mijakoski, Dragan, Bislimovska-Karadzhinska, Jovanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290446/
https://www.ncbi.nlm.nih.gov/pubmed/30559853
http://dx.doi.org/10.3889/oamjms.2018.445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290446/
https://www.ncbi.nlm.nih.gov/pubmed/30559853
http://dx.doi.org/10.3889/oamjms.2018.445

Ejemplares similares